<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Mcconnell | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/dateidea35/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/dateidea35/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Mcconnell.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">cb8a7c6f7a4e3461ff5edf86c0536f89</guid>
				<title>Mcconnell posted an update: They were both B- and T-cell epitopes, and could recognize a [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/42034/</link>
				<pubDate>Sat, 08 Feb 2025 11:56:18 -0800</pubDate>

									<content:encoded><![CDATA[<p>They were both B- and T-cell epitopes, and could recognize a certain number of HLA molecules and had high coverage rates in different populations. Moreover, epitopes 897-913 were predicted to have possible cross-immunoprotection for SARS-CoV and SARS-CoV-2. The results of vaccine candidate sequences screening suggested that sequences (without&hellip;<span class="activity-read-more" id="activity-read-more-42034"><a href="http://www.nationalboardinstitute.com/activity/p/42034/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">e6807ecacef18512e6997d2fb9f12cf7</guid>
				<title>Mcconnell posted an update: Temporalis muscle flap is one of the most commonly used [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/37651/</link>
				<pubDate>Mon, 03 Feb 2025 11:42:21 -0800</pubDate>

									<content:encoded><![CDATA[<p>Temporalis muscle flap is one of the most commonly used flaps in orbital reconstruction. Although multiple case series in the literature have reported elevation of the flap with an open incision and a retrograde approach from the periorbital region, to the best of the authors&#8217; knowledge, no studies have reported the use of an endoscopic method.&hellip;<span class="activity-read-more" id="activity-read-more-37651"><a href="http://www.nationalboardinstitute.com/activity/p/37651/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">6feb8b3bd5e22163455ff2d67b509f36</guid>
				<title>Mcconnell posted an update: The causal role of somatic mutation and its [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/35875/</link>
				<pubDate>Sat, 01 Feb 2025 11:42:41 -0800</pubDate>

									<content:encoded><![CDATA[<p>The causal role of somatic mutation and its interrelationship with gene expression profile during tumor development has already been observed, which plays a major role to decide the cancer grades and overall survival. Accurate and robust prediction of tumor grades and patients&#8217; overall survival are important for prognosis, risk factors&hellip;<span class="activity-read-more" id="activity-read-more-35875"><a href="http://www.nationalboardinstitute.com/activity/p/35875/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a0d5920fe0bc14d8399e41f65f8f13f2</guid>
				<title>Mcconnell posted an update: Excimer laser coronary atherectomy (ELCA) is a recognized [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/34079/</link>
				<pubDate>Thu, 30 Jan 2025 11:44:52 -0800</pubDate>

									<content:encoded><![CDATA[<p>Excimer laser coronary atherectomy (ELCA) is a recognized adjunctive therapy utilized in the percutaneous management of complex coronary lesions. Studies examining its safety and utility have been limited by small sample sizes. Our study examines the determinants and outcomes of ELCA.</p>
<p> Using the British Cardiac Intervention Society&hellip;<span class="activity-read-more" id="activity-read-more-34079"><a href="http://www.nationalboardinstitute.com/activity/p/34079/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">0fd159e7c38e1afede0645981a3f47c1</guid>
				<title>Mcconnell posted an update: The promoter of the Arabidopsis thaliana β-glucosidase 19 [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/32419/</link>
				<pubDate>Tue, 28 Jan 2025 18:36:42 -0800</pubDate>

									<content:encoded><![CDATA[<p>The promoter of the Arabidopsis thaliana β-glucosidase 19 gene directs GUS expression in a seed-specific manner in transgenic Arabidopsis and tobacco. In the present study, an 898-bp putative promoter of theArabidopsis β-glucosidase 19 (AtBGLU19) gene was cloned. The bioinformatics analysis of the cis-acting elements indicated that this putative p&hellip;<span class="activity-read-more" id="activity-read-more-32419"><a href="http://www.nationalboardinstitute.com/activity/p/32419/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">3854af7c7f98ec67cc66d95c7b0eb521</guid>
				<title>Mcconnell became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/32415/</link>
				<pubDate>Tue, 28 Jan 2025 18:35:29 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>